TH96108B - Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydrochro-3-methyl-5-oxho-4H-pyrazol -4-illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (mono A Tthanolamine) - Google Patents

Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydrochro-3-methyl-5-oxho-4H-pyrazol -4-illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (mono A Tthanolamine)

Info

Publication number
TH96108B
TH96108B TH701003817A TH0701003817A TH96108B TH 96108 B TH96108 B TH 96108B TH 701003817 A TH701003817 A TH 701003817A TH 0701003817 A TH0701003817 A TH 0701003817A TH 96108 B TH96108 B TH 96108B
Authority
TH
Thailand
Prior art keywords
pyrazol
biphenyl
methyl
dimethylphenyl
hydroxy
Prior art date
Application number
TH701003817A
Other languages
Thai (th)
Other versions
TH96108A (en
Inventor
นายชิวากุมาร์ จี กาป์ไซ นายฟรานซิส เอ็กซ์ มุลเลอร์
Original Assignee
แกล๊กโซสมิธไคลน์ แอลแอลซี
Filing date
Publication date
Application filed by แกล๊กโซสมิธไคลน์ แอลแอลซี filed Critical แกล๊กโซสมิธไคลน์ แอลแอลซี
Publication of TH96108A publication Critical patent/TH96108A/en
Publication of TH96108B publication Critical patent/TH96108B/en

Links

Abstract

ที่เปิดเผยเป็นองค์ประกอบทางเภสัชกรรมรูปแบบใหม่ที่มี 3'-[(2Z)-[1-(3,4-ไดเม ทธิลฟีนิล)-1,5-ไดไฮโดร-3-เมทธิล-5-ออกโซ-4H-ไพราซอล-4-อิลลีดีน]ไฮดราซิโน]-2'-ไฮดรอกซี- [1,1'ไบฟีนิล]-3-คาร์บอกซิลิกแอซิดบิส-(โมโนเอทธาโนลามีน) (เอลตรอมโบแพกโอลามีน) และ กระบวนการสำหรับการเตรียมสารดังกล่าว Disclosed is a new form of pharmaceutical component with 3 '- ((2Z) - (1- (3,4-Dimé Tthylphenyl) -1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-illedene] hydracino] -2'-hydroxyl Oxy- [1,1 'biphenyl] -3-carboxylic acid bis- (monoethanolamine) (eltrombopagolamine) and Process for the preparation of such substances

Claims (1)

1. เม็ดยาทางเภสัชกรรมที่ประกอบอย่างเป็นสำคัญด้วย a)ปริมาณของ 3'-[(2Z)-[1-(3,4-ไดเมทธิลฟีนิล)-1,5-ไดไฮโดร-3-เมทธิล-5-ออกโซ-4H- ไพราซอล-4-อิลลีดีน]ไฮดราซิโน]-2'-ไฮดรอกซี-[1,1'-ไบฟีนิล]-3-คาร์บอกซิลิกแอซิดบิส-(โมโน- เอทธาโนลามีน)(3'[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4- ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanol1.Pharmaceutical tablet composed primarily with a) dosage of 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydro-3-). Methyl-5-oxo-4H-pyrazol-4-illedene] hydracino] -2'-hydroxy- [1,1'-biphenyl] -3- Carboxylic acid bis - (mono-ethanolamine) (3 '((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydro-3-) methyl-5-oxo-4H-pyrazol-4- ylidene] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acid bis- (monoethanol
TH701003817A 2007-08-01 Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydrochro-3-methyl-5-oxho-4H-pyrazol -4-illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (mono A Tthanolamine) TH96108B (en)

Publications (2)

Publication Number Publication Date
TH96108A TH96108A (en) 2009-06-18
TH96108B true TH96108B (en) 2009-06-18

Family

ID=

Similar Documents

Publication Publication Date Title
CY1117284T1 (en) NEW PHARMACEUTICAL COMPOSITION
BRPI0310094B8 (en) 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene] acid bis(monoethanolamine) compound hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid, pharmaceutical composition and processes for preparing said compound and pharmaceutical composition
WO2008109180A3 (en) Metalloprotease inhibitors containing a heterocyclic moiety
HRP20120004T1 (en) Dipeptidyl peptidase inhibitors for treating diabetes
UY32062A (en) BETA-SECRETASA INHIBITORS
AR052270A1 (en) PROCEDURE TO COMBAT FUNGICAL DISEASES IN LEGUMINOUS
AR058433A1 (en) DERIVATIVE OF 1,1-DIOXIDE OF 1,4-BENZOTIAZEPIN, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THIS COMPOSITE AND ITS USE
CO6321225A2 (en) SOLID CARRIER PARTICLES TO IMPROVE THE PROCESSABILITY OF A PHARMACEUTICAL AGENT
AR113778A2 (en) PHARMACEUTICAL COMPOSITION THAT COMPRISES A DIPHOSPHATE SALT OF N-[6-(CIS-2,6-DIMETHYLMORFOLIN-4-IL)PYRIDIN-3-IL]-2-METHYL-4'-(TRIFLUORMETHOXY)[1,1'- BIPHENYL]-3-CARBOXAMIDE
AR049681A1 (en) MACROLIDS PREPARED FROM ACTINOMICETS. PHARMACEUTICAL COMPOSITIONS
WO2006088814A3 (en) Dosage form and method for sustained release of a substituted pyrazine compound
ECSP045493A (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERINE POLYMORPH A
MA27669A1 (en) STABILIZED TOPICAL FORMULATIONS CONTAINING KETOPROFENE
AR057885A1 (en) ACID 1- (1- (2- ETOXIETIL) - 1- ETIL-7- (4- METHYLPIRIDIN -2- ILAMINO) - 1H PIRAZOLO (4,3-D) PIRIMIDIN -5- IL) PIPERIDINE -4- CARBOXYL AND SALTS OF THE SAME. PHARMACEUTICAL COMPOSITIONS.
CO5700723A2 (en) USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT AND PREVENT CARDIAC INSUFFICIENCY
AR088497A1 (en) PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF INHIBITORS OF DIPEPTIDIL PEPTIDASE 4 WITH ATORVASTATIN
EA200900269A1 (en) DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
TH96108B (en) Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydrochro-3-methyl-5-oxho-4H-pyrazol -4-illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (mono A Tthanolamine)
EA200300692A1 (en) ANTI-INFLAMMATORY AND ANTI-INFLAMMATORY COMPOSITIONS CONTAINING CYCLOOXIGASE-2 INHIBITORS
TH96108A (en) Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydro-3-methyl-5-oxo-4H-pyrazol- 4- illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (monoate Thanolamine)
AR089710A1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS OF A HEPATITIS C VIRUS INHIBITOR
UA96261C2 (en) Pharmaceutical compositions containing eltrombopag olamine and processes for the preparation thereof
TH80320A (en) N - [(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amines, their preparations and therapeutic uses of these substances.
CL2008001413A1 (en) COMPOUNDS DERIVED FROM AMINOAZACICLIL-3-SULFONAMIDS, 5-HYDROXYTHYRIPTAMINE-6 LIGANDS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A CENTRAL NERVOUS SYSTEM DISORDER
UY29630A1 (en) METHODS AND DOSAGE FORMS TO REDUCE THE SIDE EFFECTS OF CARBAMATE COMPOUNDS